These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21466228)

  • 1. Mechanism of androgen receptor antagonism by bicalutamide in the treatment of prostate cancer.
    Osguthorpe DJ; Hagler AT
    Biochemistry; 2011 May; 50(19):4105-13. PubMed ID: 21466228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of R-bicalutamide switching from androgen receptor antagonist to agonist induced by amino acid mutations using molecular dynamics simulations and free energy calculation.
    Liu H; Han R; Li J; Liu H; Zheng L
    J Comput Aided Mol Des; 2016 Dec; 30(12):1189-1200. PubMed ID: 27848066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction mechanism exploration of R-bicalutamide/S-1 with WT/W741L AR using molecular dynamics simulations.
    Liu H; An X; Li S; Wang Y; Li J; Liu H
    Mol Biosyst; 2015 Dec; 11(12):3347-54. PubMed ID: 26442831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learning from estrogen receptor antagonism: structure-based identification of novel antiandrogens effective against multiple clinically relevant androgen receptor mutants.
    Liu B; Geng G; Lin R; Ren C; Wu JH
    Chem Biol Drug Des; 2012 Mar; 79(3):300-12. PubMed ID: 22151347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor.
    Azhagiya Singam ER; Tachachartvanich P; La Merrill MA; Smith MT; Durkin KA
    J Phys Chem B; 2019 Sep; 123(36):7657-7666. PubMed ID: 31431014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer.
    Bassetto M; Ferla S; Pertusati F; Kandil S; Westwell AD; Brancale A; McGuigan C
    Eur J Med Chem; 2016 Aug; 118():230-43. PubMed ID: 27131065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational dynamics of androgen receptors bound to agonists and antagonists.
    Gim HJ; Park J; Jung ME; Houk KN
    Sci Rep; 2021 Aug; 11(1):15887. PubMed ID: 34354111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC; Astapova I; Hollenberg AN; Balk SP
    Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical biosensor analysis in studying new synthesized bicalutamide analogs binding to androgen receptor.
    Fortugno C; Varchi G; Guerrini A; Carrupt PA; Bertucci C
    J Pharm Biomed Anal; 2014 Jul; 95():151-7. PubMed ID: 24682014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog-Thalidomide PROTACs.
    Kim GY; Song CW; Yang YS; Lee NR; Yoo HS; Son SH; Lee SJ; Park JS; Lee JK; Inn KS; Kim NJ
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33926033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure determination of chiral sulfoxide in diastereomeric bicalutamide derivatives.
    Li W; Hwang DJ; Cremer D; Joo H; Kraka E; Kim J; Ross CR; Nguyen VQ; Dalton JT; Miller DD
    Chirality; 2009 Jun; 21(6):578-83. PubMed ID: 18726944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preliminary investigations into novel 1,2,3-triazole-derived androgen receptor antagonists inspired by bicalutamide.
    Altimari JM; Niranjan B; Risbridger GP; Schweiker SS; Lohning AE; Henderson LC
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4948-53. PubMed ID: 25301770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for antagonism and resistance of bicalutamide in prostate cancer.
    Bohl CE; Gao W; Miller DD; Bell CE; Dalton JT
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6201-6. PubMed ID: 15833816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Steroidal Androgen Receptor Antagonists and Prostate Cancer: A Survey on Chemical Structures Binding this Fast-Mutating Target.
    Ferroni C; Varchi G
    Curr Med Chem; 2019; 26(33):6053-6073. PubMed ID: 30209993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer.
    Kandil SB; McGuigan C; Westwell AD
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations.
    Bisson WH; Abagyan R; Cavasotto CN
    J Mol Graph Model; 2008 Nov; 27(4):452-8. PubMed ID: 18805032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light-activated ruthenium (II)-bicalutamide prodrugs for prostate cancer.
    Zhao J; Liu N; Sun S; Gou S; Wang X; Wang Z; Li X; Zhang W
    J Inorg Biochem; 2019 Jul; 196():110684. PubMed ID: 31054419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor.
    Masiello D; Cheng S; Bubley GJ; Lu ML; Balk SP
    J Biol Chem; 2002 Jul; 277(29):26321-6. PubMed ID: 12015321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.
    Takeda K; Hara N; Nishiyama T; Tasaki M; Ishizaki F; Tomita Y
    BMC Cancer; 2016 May; 16():332. PubMed ID: 27225190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer.
    Huang R; Han J; Liang X; Sun S; Jiang Y; Xia B; Niu M; Li D; Zhang J; Wang S; Wei W; Liu Q; Zheng W; Zhang G; Song Y; Panga D
    Cell Physiol Biochem; 2017; 43(6):2212-2225. PubMed ID: 29069648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.